KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

Glaze 80 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

80 MG

 

GENERIC NAME:

GLICLAZIDE

 

MANUFACTURER:

SPIMACO

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

 

SIDE EFFECTS:

Hypoglycemia-mild, including nocturnal hypoglycemia

weight gain

Erythema multiforme or exfoliative dermatitis

hypoglycemia-severe

Dilutional hyponatremia, hypo-osmolality, or syndrome of inappropriate antidiuretic hormone (SIADH)

Anemia, aplastic or hemolytic

blood dyscrasias, specifically, agranulocytosis, leukopenia, pancytopenia

cholestasis, cholestatic jaundice, hepatic function impairment, hepatic porphyria, hepatitis, or porphyria cutanea tarda

eosinophilia

thrombocytopenia

Changes in sense of taste

dizziness

drowsiness

gastrointestinal disturbances

headache

polyuria

Blurred vision and/or changes in accommodation

photosensitivity

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Allergy to sulfonylurea antidiabetic agents, sulfonamides, or thiazide-type diuretics

>> Diarrhea, severe

>> Gastroparesis

>> Intestinal obstruction

>> Vomiting, prolonged

>> Other conditions causing delayed food absorption

>> Hepatic disease

>> Hyperglycemia-causing conditions

Female hormone changes

Fever, high

Hyperadrenalism, not optimally controlled

Infection, severe

Psychological stress

>> Hyperthyroidism, not optimally controlled

>> Hypoglycemia-causing conditions

Adrenal insufficiency, not optimally controlled

Debilitated physical condition

Malnutrition

Pituitary insufficiency, not optimally controlled

Hypothyroidism, not optimally controlled

>> Renal function impairment

 

ADULT DOSE:

Antidiabetic-Initial: Oral, 160 mg two times a day with meals. Maintenance: Oral, 80 to 320 mg a day with meals.

 

MAXIMUM ADULT DOSE:

320 mg daily.

 

PEDIATRIC DOSE:

Safety and efficacy have not been established.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

Antidiabetic-Initial: Oral, 160 mg two times a day with meals. Maintenance: Oral, 80 to 320 mg a day with meals.

 

 

PREVIOUS

  

NEXT